Why is HWKN Stock Up Today?
AI-generated explanation by Rhea-AI. How Rhea-AI works. Not financial advice.
What Changed
Price Move History
- Daily moves over 5%
- 12 252 sessions, October 24, 2025 to October 26, 2026
- Largest daily move
- -12.5% close of June 29, 2026
- 1-year change
- -18.7% closing prices, October 24, 2025 to October 26, 2026
- 1-month change
- +5% closing prices, September 25, 2026 to October 26, 2026
Company Description
Hawkins, Inc. (NASDAQ: HWKN) is a water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for customers across its Water Treatment, Food & Health Sciences, and Industrial Solutions segments. According to company disclosures, Hawkins was founded in 1938 and is headquartered in Roseville, Minnesota, with a network of facilities serving customers in multiple U.S. states. The company is incorporated in Minnesota and its common stock trades on the Nasdaq exchange under the ticker HWKN.
Business Segments and Operations
Hawkins organizes its operations into three primary reporting segments: Water Treatment, Food & Health Sciences, and Industrial Solutions. These segments reflect how the company manages its operations and allocates resources, as described in its public communications and SEC filings.
Water Treatment is a core focus of Hawkins. The company states that it formulates, manufactures, distributes, and blends products for water treatment customers. This segment serves markets that use chemicals and related products to treat water, and Hawkins has expanded this business through acquisitions, including WaterSurplus and StillWaters Technology, Inc. The company has also acquired Redbird Chemical, Inc., which distributes chemicals to water treatment and industrial customers in eastern Texas. Hawkins has indicated that it is using these acquisitions to grow its water treatment presence, particularly in the southern United States.
Food & Health Sciences includes Hawkins’ nutrition, food, agriculture, and pharmaceutical businesses. The company has described this segment as part of its specialty ingredients focus, supplying ingredients and related products to customers in these areas. In its financial reporting, Hawkins notes that Food & Health Sciences segment performance is influenced by sales volumes and pricing dynamics, including competitive pricing pressures in certain product lines.
Industrial Solutions encompasses Hawkins’ industrial-focused products and services. The company reports that this segment includes manufactured, blended, and repackaged products sold into industrial markets. Segment results are affected by sales volumes, operating costs, and pricing conditions. Hawkins has indicated that both its Water Treatment and Industrial Solutions segments have delivered double-digit revenue growth in certain reporting periods.
Water Treatment and Specialty Ingredients Focus
Across its operations, Hawkins describes itself as a leading water treatment and specialty ingredients company. It emphasizes its role in formulating, manufacturing, distributing, and blending products tailored to the needs of its Water Treatment, Food & Health Sciences, and Industrial Solutions customers. The company highlights that it creates value through customer service and support, quality products, and personalized applications.
Hawkins has reported that it operates dozens of facilities in multiple U.S. states, supporting a broad geographic footprint for its segments. The company has also stated that it has generated hundreds of millions of dollars in annual revenue and employs a workforce of approximately one thousand people, underscoring its scale within its chosen markets.
Growth Through Acquisitions and Segment Realignment
Public announcements and filings show that Hawkins has pursued growth through acquisitions and segment realignment. The company has completed acquisitions such as WaterSurplus, StillWaters Technology, Inc., and Redbird Chemical, Inc. Hawkins has described WaterSurplus as bringing design, engineering, and filtration systems capabilities into its Water Treatment segment, enabling a combined offering of equipment and chemicals for water treatment customers in the United States. StillWaters Technology and Redbird Chemical expand Hawkins’ customer base and distribution reach in Alabama and eastern Texas, respectively, particularly in water treatment and industrial markets.
Hawkins has also realigned its reporting structure. It reports that, beginning in its fiscal 2026, it reorganized its segments into Water Treatment, Food & Health Sciences, and Industrial Solutions to better reflect organizational changes and how management operates the business. Under this structure, Food & Health Sciences includes the nutrition, food, agriculture, and pharmaceutical businesses, which were previously part of the historic Industrial segment.
Financial Reporting and Performance Metrics
Hawkins provides detailed financial information in its earnings releases and SEC filings. The company reports sales, gross profit, operating income, net income, and segment performance for each quarter and fiscal period. It also discloses non-GAAP measures such as adjusted EBITDA, which it defines as net income adjusted for interest expense, income tax expense, amortization of intangibles, depreciation, non-cash compensation expense, and certain non-recurring acquisition-related items. Management states that adjusted EBITDA is used internally to understand, manage, and evaluate the business and as a key compliance measure under its credit agreement.
Hawkins’ financial discussions highlight factors that influence its results, including sales volumes, pricing, acquisition-related expenses, amortization of intangibles, interest expense, and changes in its LIFO reserve. The company also discloses its effective income tax rate and notes that it is affected by projected taxable income, permanent items, and state taxes.
Capital Structure, Dividends, and Governance
Hawkins reports on its capital structure, including total debt, working capital, and leverage ratio based on trailing twelve-month adjusted EBITDA. The company has disclosed that it uses its cash flow to fund acquisitions, invest in its business, and manage its debt levels.
The company’s board of directors has authorized regular cash dividends. Hawkins states that it has paid a dividend consistently since 1985 and has announced increases in its quarterly cash dividend per share in its public releases. Dividend decisions are communicated through board actions and press releases.
Corporate governance matters, such as the election of directors, ratification of the independent registered public accounting firm, and advisory votes on executive compensation, are reported through proxy materials and Form 8-K filings. Hawkins’ SEC filings indicate that it is subject to U.S. securities regulations and that it communicates material business and financial information through its website, press releases, and SEC filings.
Regulatory Filings and Investor Communications
Hawkins files periodic and current reports with the U.S. Securities and Exchange Commission, including Form 8-K filings related to earnings releases, segment realignments, and shareholder meeting results. The company has stated that it uses its website, investor relations materials, press releases, and SEC filings to communicate with investors and other interested parties. It has also indicated that information made available through its website may be deemed material.
Through these channels, Hawkins provides updates on its financial performance, acquisitions, reporting segment changes, and participation in investor conferences hosted by firms such as Sidoti & Company and Seaport Research Partners. These events offer opportunities for institutional investors and other stakeholders to engage with Hawkins’ management and learn more about its strategy and operations.
Stock Information and Sector Classification
Hawkins, Inc. is classified in the broader manufacturing sector and is associated with activities such as chemical and ingredient production and distribution. The company’s stock trades on the Nasdaq under the symbol HWKN, and it is identified in industry references as a water treatment and specialty ingredients company. Investors researching HWKN stock can review Hawkins’ public filings, earnings releases, and segment information to understand how the Water Treatment, Food & Health Sciences, and Industrial Solutions segments contribute to its overall performance.
Stock Performance
Hawkins (HWKN) closed at $135.44 on October 26, 2026. Over the past 12 months, the price has lost 18.7%.
HWKN Metrics & Rankings
Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Hawkins has 10 recent news articles, with the latest published today. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include dividends, earnings date, acquisition, earnings. View all HWKN news →
SEC Filings
Hawkins has filed 10 recent SEC filings, including 5 Form 4, 3 Form 8-K, 1 Form 10-Q, 1 Form SCHEDULE 13G. The most recent filing was submitted on October 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HWKN SEC filings →
Insider Radar
Insider buying activity at Hawkins over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Hawkins generated $1.1B in revenue in FY2026, retaining a 22.6% gross margin, operating income reached $121.3M (11.2% operating margin), and net income was $81.5M, reflecting a 7.5% net profit margin. Diluted earnings per share stood at $3.91. The company generated $144.3M in operating cash flow. The current ratio was 2.21, measuring current assets divided by current liabilities.
Upcoming Events
Q2 Fiscal 2027 Release
Dividend record date
Dividend payment
Hawkins has 3 upcoming scheduled events. The next event, "Q2 Fiscal 2027 Release", is scheduled for October 26, 2026 (today). 1 of them is an earnings release or call. 2 of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the HWKN stock price.
Short Interest History
Short interest in Hawkins (HWKN) currently stands at 1.3 million shares, down 1.6% from the previous reporting period, representing 6.5% of the float. Since October 2025, short interest has increased by 14.9%.
Days to Cover History
Days to cover for Hawkins (HWKN) currently stands at 7.5 days, up 17.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 4.7 to 14.4 days.
HWKN Company Profile & Sector Positioning
Hawkins (HWKN) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the NASDAQ. Among dividend-paying stocks, HWKN ranks #1,924 by dividend yield.
Investors comparing HWKN often look at related companies in the same sector, including H.B. Fuller Company (FUL), Cabot Corporation (CBT), Avient Corporation (AVNT), Perimeter Solutions, Inc. (PRM), and Sensient Technology Corporation (SXT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HWKN's relative position within its industry.
Hawkins (HWKN) reported second-quarter fiscal 2027 revenue of $313.8 million, up 12% from the same period a year earlier. For the three months ended September 27, 2026, net income rose 23% to $27.8 million and diluted earnings per share increased 23% to $1.34. Gross profit increased 13% to $76.6 million, while adjusted EBITDA, a non-GAAP earnings measure, rose 16% to $59.1 million.
Water Treatment sales grew 16%, Food & Health Sciences 5%, and Industrial Solutions 10%. Six-month operating cash flow increased 6% to $75.5 million. Hawkins repaid $15.0 million of debt and completed acquisitions of Dave Symonds & Associates during the quarter and Eagle Labs afterward. Food & Health Sciences gross profit fell 4%. Hawkins expects second-half trends consistent with the first half, but a $6.2 million expense reduction that benefited the second half of fiscal 2026 will not recur.